Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

ACR to call on MedCAC to recommend full Medicare coverage for CT lung cancer screening

At an April 30 meeting, Ella Kazerooni, MD, chair of the American College of Radiology (ACR) Committee on Lung Cancer Screening, will urge the 2014 Medicare Evidence Development and Coverage Advisory Committee (MedCAC), to recommend national Medicare coverage of low-dose computed tomography screening for patients at high risk for lung cancer.

Device to allow MRI measurements of tumor oxygen levels

The ability to measure a tumor’s oxygen levels could help guide treatment decisions, and now, for the first time, a method to reliably and noninvasively take such measurements could soon be available.

3D implantable marker reported to clearly identify surgical area in breast cancer patients

The BioZorb™ three-dimensional surgical marker improved the ability of radiation oncologists to target radiation treatment for breast cancer, according to a scientific presentation at the 2014 American Brachytherapy Society (ABS) Annual Meeting.

MRI could be a valuable asset in certain prostate cancer patient populations

MRI could be of value in the diagnosis of prostate cancer in patients with histories of negative biopsies and elevated levels of prostate-specific antigen (PSA), according to a study published in the May issue of Academic Radiology. 

Drug fails to improve erectile function in prostate cancer patients

Daily use of tadalafil does not result in improved erectile function amongst men undergoing radiotherapy for prostate cancer, according to a study published on April 2 by the Journal of the American Medical Association.

Promising biomarker predicts survival during chemoembolization of hepatocellular carcinoma

An association between intraprocedural tumor perfusion reduction during chemoembolization and transplant-free survival (TFS) implicates the utility of transcatheter intraarterial perfusion (TRIP) MRI-measured tumor perfusion reduction as an intraprocedural imaging biomarker during chemoembolization, according to a study published March 28 in Radiology.

Thumbnail

Really old school: Archaeologists unearth ancient example of human cancer

Researchers at the British Museum and Durham University in the U.K. have located a skeleton more than 3,000 years old that they say represents the oldest complete example of a human being with metastatic cancer.

Medical organizations call for Medicare coverage of CT lung cancer screening

Forty-one of the nation’s largest medical organizations and patient advocacy groups, including the American College of Radiology (ACR), issued a joint letter to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group calling for lung cancer screening coverage in line with recent recommendations from the U.S. Preventive Services Task Force (USPSTF).

Displaying 617 - 624 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.